Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

Sezary Syndrome · Mycosis Fungoides

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Stanford Cancer Center, Stanford, California, United States
Contact: Study coordinator (Zainab Ahmed) · zahmed01@stanford.edu · 650-387-4436
Contact: Principal Investigator (Youn H Kim, MD)

Study leads

Youn H Kim, MD
Principal Investigator
Stanford University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Folliculotropic Mycosis Fungoides · Primary Cutaneous T-Cell Non-Hodgkin Lymphoma · Sezary Syndrome

Abroad (travel likely)RecruitingPHASE2

Scottsdale, United States · Duarte, United States

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

Folliculotropic Mycosis Fungoides · Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma · Recurrent Mycosis Fungoides

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · New York, United States

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Mycosis Fungoides · Lymphomatoid Papulosis · Sezary Syndrome

Abroad (travel likely)RecruitingPHASE2

Stanford, United States · Basking Ridge, United States

A Registry for People With T-cell Lymphoma

T-cell Lymphoma · NK-Cell Lymphoma · T-cell Prolymphocytic Leukemia

Abroad (travel likely)Recruiting

Duarte, United States · San Diego, United States